Caring Brands (NASDAQ:CABR – Get Free Report) posted its earnings results on Thursday. The company reported ($0.10) earnings per share (EPS) for the quarter, FiscalAI reports.
Caring Brands Price Performance
Caring Brands stock traded up $0.07 during mid-day trading on Friday, reaching $1.38. 54,058 shares of the company were exchanged, compared to its average volume of 89,318. The firm has a market cap of $12.55 million and a PE ratio of -1.86. The company has a debt-to-equity ratio of 0.03, a current ratio of 5.66 and a quick ratio of 5.62. Caring Brands has a 12 month low of $0.71 and a 12 month high of $5.35. The company has a fifty day simple moving average of $1.34 and a 200-day simple moving average of $1.12.
Wall Street Analyst Weigh In
Separately, Weiss Ratings raised Caring Brands from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, June 11th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has an average rating of “Sell”.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Caring Brands stock. Jane Street Group LLC acquired a new position in Caring Brands, Inc. (NASDAQ:CABR – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 34,446 shares of the company’s stock, valued at approximately $30,000. Jane Street Group LLC owned 0.25% of Caring Brands at the end of the most recent reporting period.
About Caring Brands
We are a wellness consumer products company. We offer several over-the-counter, or (OTC) and cosmetic, consumer products. Our method of operation is to ensure that (1) the mechanism of action of all products is established, (2) efficacy is determined through controlled clinical trials, (3) products are protected by issued and filed patents, and (4) products have acceptable commercial stability. Prior to its Q3 2022 commercial launch in India as a treatment for vitiligo and psoriasis, Photocil was briefly launched in the United States markets from December 2022 until February 2023, however, was subsequently removed from the market due to insufficient sales resulting from the lack of a dedicated sales and marketing team.
Further Reading
- Five stocks we like better than Caring Brands
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
- Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
Receive News & Ratings for Caring Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Caring Brands and related companies with MarketBeat.com's FREE daily email newsletter.
